Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7168 | 1398 | 31.9 | 83% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
118 | 3 | EPSTEIN BARR VIRUS//LYMPHOMA//HODGKINS DISEASE | 69002 |
109 | 2 | CHRONIC LYMPHOCYTIC LEUKEMIA//HODGKINS DISEASE//MANTLE CELL LYMPHOMA | 25223 |
7168 | 1 | INTERIM PET//LYMPHOMA//INTERIM PET CT | 1398 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | INTERIM PET | authKW | 266239 | 1% | 76% | 16 |
2 | LYMPHOMA | authKW | 225642 | 22% | 3% | 308 |
3 | INTERIM PET CT | authKW | 220223 | 1% | 92% | 11 |
4 | FDG PET | authKW | 149619 | 8% | 6% | 106 |
5 | HODGKIN LYMPHOMA | authKW | 126885 | 6% | 7% | 82 |
6 | NUCL MED | address | 125437 | 35% | 1% | 489 |
7 | LYMPHOMA RADIONUCLIDE STUDIES | authKW | 118906 | 1% | 78% | 7 |
8 | LYMPHOMA CT | authKW | 112309 | 1% | 43% | 12 |
9 | DEAUVILLE CRITERIA | authKW | 109203 | 0% | 100% | 5 |
10 | PET CT | authKW | 108569 | 9% | 4% | 121 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Radiology, Nuclear Medicine & Medical Imaging | 21235 | 48% | 0% | 665 |
2 | Hematology | 6704 | 22% | 0% | 301 |
3 | Oncology | 5352 | 33% | 0% | 459 |
4 | Medicine, General & Internal | 68 | 5% | 0% | 70 |
5 | Pediatrics | 51 | 3% | 0% | 44 |
6 | Pathology | 8 | 1% | 0% | 20 |
7 | Education, Scientific Disciplines | 4 | 1% | 0% | 7 |
8 | Medicine, Research & Experimental | 3 | 2% | 0% | 26 |
9 | Transplantation | 2 | 1% | 0% | 9 |
10 | Primary Health Care | -0 | 0% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NUCL MED | 125437 | 35% | 1% | 489 |
2 | PET IMAGING ST THOMAS | 91000 | 0% | 83% | 5 |
3 | B R ORT MED | 43681 | 0% | 100% | 2 |
4 | INNOVAT STAT | 32758 | 0% | 50% | 3 |
5 | HEMATOL L SERAGNOLI | 29119 | 0% | 67% | 2 |
6 | OFF EXECUT VICE P IDENT PHYS IN CHIEF | 29119 | 0% | 67% | 2 |
7 | UOC EMATOL 1 | 29119 | 0% | 67% | 2 |
8 | NUCL MED SERV | 25419 | 4% | 2% | 60 |
9 | ABT INNERE MED HAMATOL ONKOL INFEKT KRANKHEITEN K | 21841 | 0% | 100% | 1 |
10 | ABT LUNGENKRANKE | 21841 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 29685 | 5% | 2% | 66 |
2 | LEUKEMIA & LYMPHOMA | 19754 | 6% | 1% | 83 |
3 | JOURNAL OF NUCLEAR MEDICINE | 11391 | 5% | 1% | 73 |
4 | NUCLEAR MEDICINE COMMUNICATIONS | 10136 | 3% | 1% | 44 |
5 | MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE | 9946 | 1% | 3% | 18 |
6 | CLINICAL NUCLEAR MEDICINE | 9908 | 4% | 1% | 55 |
7 | ANNALS OF ONCOLOGY | 9818 | 4% | 1% | 61 |
8 | ANNALS OF NUCLEAR MEDICINE | 9580 | 2% | 2% | 29 |
9 | REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR | 8070 | 1% | 4% | 10 |
10 | NUKLEARMEDIZIN-NUCLEAR MEDICINE | 6754 | 1% | 2% | 19 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INTERIM PET | 266239 | 1% | 76% | 16 | Search INTERIM+PET | Search INTERIM+PET |
2 | LYMPHOMA | 225642 | 22% | 3% | 308 | Search LYMPHOMA | Search LYMPHOMA |
3 | INTERIM PET CT | 220223 | 1% | 92% | 11 | Search INTERIM+PET+CT | Search INTERIM+PET+CT |
4 | FDG PET | 149619 | 8% | 6% | 106 | Search FDG+PET | Search FDG+PET |
5 | HODGKIN LYMPHOMA | 126885 | 6% | 7% | 82 | Search HODGKIN+LYMPHOMA | Search HODGKIN+LYMPHOMA |
6 | LYMPHOMA RADIONUCLIDE STUDIES | 118906 | 1% | 78% | 7 | Search LYMPHOMA+RADIONUCLIDE+STUDIES | Search LYMPHOMA+RADIONUCLIDE+STUDIES |
7 | LYMPHOMA CT | 112309 | 1% | 43% | 12 | Search LYMPHOMA+CT | Search LYMPHOMA+CT |
8 | DEAUVILLE CRITERIA | 109203 | 0% | 100% | 5 | Search DEAUVILLE+CRITERIA | Search DEAUVILLE+CRITERIA |
9 | PET CT | 108569 | 9% | 4% | 121 | Search PET+CT | Search PET+CT |
10 | HODGKINS DISEASE | 103037 | 8% | 4% | 106 | Search HODGKINS+DISEASE | Search HODGKINS+DISEASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BARRINGTON, SF , MIKHAEEL, NG , KOSTAKOGLU, L , MEIGNAN, M , HUTCHINGS, M , MUELLER, SP , SCHWARTZ, LH , ZUCCA, E , FISHER, RI , TROTMAN, J , ET AL (2014) ROLE OF IMAGING IN THE STAGING AND RESPONSE ASSESSMENT OF LYMPHOMA: CONSENSUS OF THE INTERNATIONAL CONFERENCE ON MALIGNANT LYMPHOMAS IMAGING WORKING GROUP.JOURNAL OF CLINICAL ONCOLOGY. VOL. 32. ISSUE 27. P. 3048 -+ | 103 | 74% | 160 |
2 | KOSTAKOGLU, L , CHESON, BD , (2014) CURRENT ROLE OF FDG PET/CT IN LYMPHOMA.EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 41. ISSUE 5. P. 1004-1027 | 126 | 73% | 14 |
3 | CHESON, BD , (2011) ROLE OF FUNCTIONAL IMAGING IN THE MANAGEMENT OF LYMPHOMA.JOURNAL OF CLINICAL ONCOLOGY. VOL. 29. ISSUE 14. P. 1844 -1854 | 90 | 89% | 102 |
4 | BARRINGTON, SF , MIKHAEEL, NG , (2014) WHEN SHOULD FDG-PET BE USED IN THE MODERN MANAGEMENT OF LYMPHOMA?.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 164. ISSUE 3. P. 315-328 | 78 | 86% | 15 |
5 | BABA, S , ABE, K , ISODA, T , MARUOKA, Y , SASAKI, M , HONDA, H , (2011) IMPACT OF FDG-PET/CT IN THE MANAGEMENT OF LYMPHOMA.ANNALS OF NUCLEAR MEDICINE. VOL. 25. ISSUE 10. P. 701 -716 | 82 | 90% | 16 |
6 | SEAM, P , JUWEID, ME , CHESON, BD , (2007) THE ROLE OF FDG-PET SCANS IN PATIENTS WITH LYMPHOMA.BLOOD. VOL. 110. ISSUE 10. P. 3507-3516 | 77 | 86% | 146 |
7 | KIRBY, AM , MIKHAEEL, NG , (2007) THE ROLE OF FDG PET IN THE MANAGEMENT OF LYMPHOMA: WHAT IS THE EVIDENCE BASE?.NUCLEAR MEDICINE COMMUNICATIONS. VOL. 28. ISSUE 5. P. 335-354 | 91 | 87% | 28 |
8 | CHESON, BD , PFISTNER, B , JUWEID, ME , GASCOYNE, RD , SPECHT, L , HORNING, SJ , COIFFIER, B , FISHER, RI , HAGENBEEK, A , ZUCCA, E , ET AL (2007) REVISED RESPONSE CRITERIA FOR MALIGNANT LYMPHOMA.JOURNAL OF CLINICAL ONCOLOGY. VOL. 25. ISSUE 5. P. 579 -586 | 34 | 79% | 1638 |
9 | SHAH, GL , MOSKOWITZ, CH , (2016) ROLE OF POSITRON EMISSION TOMOGRAPHY IN DIFFUSE LARGE B-CELL LYMPHOMA.HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. VOL. 30. ISSUE 6. P. 1215 -+ | 68 | 92% | 0 |
10 | SPECHT, L , (2007) 2-[18F]FLUORO-2-DEOXYGLUCOSE POSITRON-EMISSION TOMOGRAPHY IN STAGING, RESPONSE EVALUATION, AND TREATMENT PLANNING OF LYMPHOMAS.SEMINARS IN RADIATION ONCOLOGY. VOL. 17. ISSUE 3. P. 190-197 | 90 | 81% | 16 |
Classes with closest relation at Level 1 |